Oneblood, Inc.

Oneblood, Inc., a tax-exempt nonprofit community blood bank headquartered in Orlando, Florida, supplies whole blood, blood components (red blood cells, plasma), and blood compatibility testing services to the Department of Veterans Affairs as a prime contractor on delivery orders, with 99% of recent awards held as a prime and no set-aside designations across the portfolio.

Oneblood's customer concentration is extreme and single-agency: the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 accounts for 122 of 241 total awards and $191.5 million of the combined $201.4 million potential value across all awards—94.9% by dollars. Veterans Integrated Service Network 6 contributes 2 awards valued at $2.7 million. The remaining three customer agencies (Food and Drug Administration, Health Resources and Services Administration, and a subsidiary line under DVA itself) account for 7 awards and represent a de minimis share of portfolio value. SCI-reported invoiced revenue in FY2024 totaled $2.9 million across 30.5 FTEs on a prime federal services contract; no SCI-reportable service contracts invoiced in FY2022 or FY2023, with FTE levels at 6.1 and 0 respectively. On SCI-captured prime contracts, government-paid hourly rates ran at a consistent $45.00/hr across the 10th, median, and 90th percentiles. Across SCI-reportable prime contracts, Oneblood performed 100% of labor internally and used no subcontractors on the reporting threshold contracts, though in its sub role it delivers donor-deferral data collection, infectious-disease surveillance analysis, and biospecimen provision to Vitalant on transfusion-transmissible infections monitoring contracts (awards in December 2023, February 2025, and January 2026).

Oneblood's prime contract footprint is anchored to four active indefinite-delivery contracts with VISN 8 and VISN 6. The largest vehicle—Indefinite Delivery Contract 36C24820D0014, awarded October 1, 2023—carries a $15.18 million ceiling through November 30, 2026 for blood compatibility testing services and has generated 33 delivery orders totaling $16.4 million in potential value. A second VISN 8 IDC awarded July 1, 2025, carries a $12 million ceiling through February 28, 2026 for whole blood and blood products, with 7 delivery orders totaling $2.7 million potential value issued to date. A third vehicle awarded March 1, 2026, carries a $15.76 million ceiling through February 28, 2027 for whole blood and related products across Bay Pines, Miami, Orlando, Tampa, and West Palm Beach, Florida medical facilities. The fourth vehicle, awarded October 1, 2025, is a $2.21 million VISN 6 IDC through September 30, 2026 for blood supply delivery to Durham, North Carolina. Representative delivery orders include a $2.99 million firm-fixed-price order from VISN 8 awarded December 1, 2025, for blood compatibility testing services through November 30, 2026; a $938.6 thousand order awarded March 1, 2026, for Orlando blood and whole blood products through September 30, 2026; and a $792.9 thousand order awarded March 1, 2026, for whole blood and related products to James A. Haley Veterans' Hospital in Tampa through September 30, 2030. All contracts are single-award, firm-fixed-price vehicles with no set-asides.

Activity has been inconsistent year to year—six awards in 2022, nine in 2023, five in 2024, eleven in 2025, and eight awards in the first quarter of 2026—reflecting fluctuation in VA delivery order issuance cycles rather than organic growth. Six awards with combined potential value of $5.4 million face ultimate completion within the next twenty-four months and therefore present recompete exposure. The portfolio is heavily concentrated in NAICS 621991 (Blood and Organ Banks), which accounts for 151 of 241 awards; PSC codes reflect the dual nature of the work, with Drugs and Biologicals (58 awards), Medical and Surgical Instruments, Equipment, and Supplies (47 awards), and Reference Laboratory Testing (23 awards) as the top three categories. Place of performance spans multiple Florida VA medical facilities (Bay Pines, Miami, Orlando, Tampa, West Palm Beach, St. Petersburg) and Durham, North Carolina, with Oneblood's primary operations facility in Orlando, Florida and a secondary facility in Sand Lake, Florida.